Antithrombotic Therapy at the End of Life: The PEACE Study

"Antithrombotic Therapy at the End of Life: The PEACE Study" is a multicenter, non-profit, cross-sectional observational study. In the absence of shared guidelines, therapeutic decisions on antithrombotic drugs vary significantly according to healthcare professional training and national context, resulting in marked variability in prescribing practices. This study aims to describe the prevalence of antithrombotic prescriptions in patients referred to Palliative Care.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Palliative Care Death Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Roma, RM, 00168, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adults (≥18 years) hospitalized and referred to Palliative Care (home-based or residential) at the discretion of the attending physician.
Signed informed consent

Exclusion criteria

none

Treatment and study plan

antithrombotic drugs

Drug

use of antithrombotic drug

Primary outcomes

Prevalence of antithrombotic drug use

Time frame: at enrollment

Calculation of the prevalence of antithrombotic drug use in hospitalized patients referred to Palliative Care pathway.

Study contacts

Contact information is provided by the study sponsor or research team.

Roberto Pola

CONTACT

[email protected]

+390630157075

Rosa Talerico

CONTACT

[email protected]

+390630157075

Sponsors and collaborators

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Other

Collaborators

Ospedale Cristo Re - Roma
San Giovanni Addolorata Hospital

Registry information

Acronym: PEACE

Important dates

Study start: 2026
Primary completion: 2027
Study completion: 2027
First posted: Jan 13, 2026
Registry last updated: Jan 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting